These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 33969928)

  • 61. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multifaceted bioinformatic analysis of m6A-related ferroptosis and its link with gene signatures and tumour-infiltrating immune cells in gliomas.
    Yang Y; Hao L; Guiyang L; Haozhe P
    J Cell Mol Med; 2024 Sep; 28(17):e70060. PubMed ID: 39248438
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of Critical m
    Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X
    Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas.
    Tong S; Ye L; Xu Y; Sun Q; Gao L; Cai J; Ye Z; Tian D; Chen Q
    Transl Oncol; 2022 Dec; 26():101544. PubMed ID: 36156371
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
    Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
    Front Immunol; 2020; 11():606164. PubMed ID: 33408717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
    Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
    Front Immunol; 2021; 12():557994. PubMed ID: 34220791
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma.
    Li J; Guo Q; Xing R
    BMC Cancer; 2023 Aug; 23(1):727. PubMed ID: 37543576
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
    Zeng F; Wang K; Liu X; Zhao Z
    Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
    Luo C; Wang S; Shan W; Liao W; Zhang S; Wang Y; Xin Q; Yang T; Hu S; Xie W; Xu N; Zhang Y
    Front Immunol; 2022; 13():909189. PubMed ID: 35769464
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
    Liu G; Ma JY; Hu G; Jin H
    PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autophagy-Dependent Ferroptosis-Related Signature is Closely Associated with the Prognosis and Tumor Immune Escape of Patients with Glioma.
    Sun W; Yan J; Ma H; Wu J; Zhang Y
    Int J Gen Med; 2022; 15():253-270. PubMed ID: 35023963
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
    Wei B; Wang L; Zhao J
    Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma.
    Jiang Y; Ji Q; Long X; Wang P; Tu Z; Zhang X; Zhu X; Huang K; Li J
    Front Immunol; 2022; 13():810832. PubMed ID: 35265072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer.
    Wang H; Cheng Q; Chang K; Bao L; Yi X
    Front Cell Dev Biol; 2021; 9():807862. PubMed ID: 35071242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.